Adjuvant therapy in Parkinson's disease

Adjuvant therapy in Parkinson's disease

Bibliographic Details
Main Author:	Critchley, P. H. S.
Published:	University of Cambridge 1991
Subjects:	615.1
Online Access:	http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.598153

Similar Items

The non dopaminergic neuropharmacology of idiopathic Parkinson's disease
by: Foy, Catherine Mary Louise
Published: (2000)

The crystal and molecular structures of some small molecule systems of pharmacological interest
by: Critchley, S. R.
Published: (1978)

Experimental and in silico computational studies of novel nanoparticle vaccine adjuvants
by: Maughan, C. N.
Published: (2017)

A role for the Parkinson's disease kinase LRRK2 in endo-lysosomal and cytoskeletal function
by: Pellegrini, Laura
Published: (2017)

Particulate carriers as immunological adjuvants
by: Almeida, Antonio J. L.
Published: (1993)

Neuroprotective effect of GLP-1 receptor agonist Exendin-4 in rat models of Parkinson's disease
by: Harkavyi, Alexander
Published: (2009)

Neuroprotective effects and mechanisms of the activation of group III metabotropic glutamate receptor in rodent models of Parkinson's disease
by: Chan, Hugh Hiu-Nam
Published: (2010)

The role of some putative mediators of peripheral nociceptor activation in adjuvant-induced experimental arthritis
by: Gauldie, Stephan D.
Published: (2002)

Exendin-4 promotes recovery of both behavioural and neurochemical deficits in a "Pre-motor" rodent model of parkinson's disease
by: Rampersaud, Nazir
Published: (2011)

Intravenously administered gene therapy for neuronopathic Gaucher disease
by: Massaro, Giulia
Published: (2018)

Exploring the role of inflammatory mediators in the 1-methyl-4-phenly-1,2,3,6,-tetrahydropyridine (MPTP) mouse model of Parkinson's disease
by: Martin, Heather Louise
Published: (2010)

A direct interaction between the Parkinson's disease protein leucine-rich repeat kinase 2 and specific β-tubulin isoforms regulates tubulin acetylation
by: Spain, V.
Published: (2015)

The development of gene therapy for Niemann-Pick Type C disease
by: Hughes, Michael
Published: (2017)

Drug action on anxiety models with special reference to serotonergic mechanisms
by: Critchley, Martyn A. E.
Published: (1988)

Diazanaphthalenes as probes of molybdenum hydroxylase activity
by: Critchley, David J. P.
Published: (1989)

Haemodynamic disturbance in cirrhosis : a study of humoral mediators and implications for therapy
by: Forrest, E. H.
Published: (1997)

Functional aspects of thrombolytic therapy
by: Gemmill, John Douglas
Published: (1993)

Copper chelation as an Anti-angiogenic therapy
by: Lowndes, Sarah
Published: (2009)

Novel Drug Delivery Approaches to Photodynamic Therapy
by: Morrow, D. I. J.
Published: (2008)

Novel potential peptide therapeutics for tuberculosis therapy
by: Scotti, F.
Published: (2017)

An evaluation of the role of leukotriene receptor antagonist therapy in asthma
by: Dempsey, Owen J.
Published: (2001)

The vitreous as a depot to prolong the action of ocular therapies
by: Shiekh Hassan Awwad, S.
Published: (2016)

Nanoparticle theranostics for applications in cancer diagnostics and cancer therapy
by: Hobson, N. J.
Published: (2017)

The Role of Pharmacokinetics in Optimising Antiretroviral Therapy in HIV-Infected Patients
by: Else, Laura Jayne
Published: (2009)

Application of pharmacokinetics and pharmacogenomics to tailor anti-cancer and immunosuppressive therapy
by: Hawwa, Ahmed Fayeq
Published: (2004)

Poly(ethylene) glycol based delivery systems for nucleic acid therapies
by: Iemsam-Arng, J.
Published: (2013)

Formulation and assessment of taste masked combination therapies for the treatment of paediatric tuberculosis
by: Keating, Alison
Published: (2017)

Synthesis of chemical modifiers of nitric oxide release for use in cancer therapy
by: Ulhaq, Saraj
Published: (1997)

GABA transmission in the basal ganglia : pathophysiological and therapeutic implications for Parkinson's disease
by: Chadha, Anita
Published: (2000)

A study on the potential of cyclosporin A in combination with α-difluoromethylornithine as an antitumour therapy
by: McLachlan, G.
Published: (1993)

Mechanisms underlying the erythemal response to topical 5-aminolaevulinic acid photodynamic therapy
by: Brooke, Rebecca C. C.
Published: (2010)

Design and synthesis of isoform selective inhibitors of nitric oxide synthase for cancer therapy
by: Goodyer, Claire Louise Margaret
Published: (2003)

An integrated disease and medicines management programme for patients with chronic obstructive pulmonary disease (COPD)
by: Al-Khdour, Maher Rateb
Published: (2008)

Identification of novel disease-causing variants in rare diseases using trio exome sequencing
by: Pepler, A.
Published: (2017)

Cellular and molecular mechanisms of non-response to anti-TNF therapy in rheumatoid arthritis patients
by: Coulthard, Lydia Ruth
Published: (2009)

Studies towards a concise synthesis of the duocarmycin SA subunit for antibody directed therapy
by: Baig, Farah
Published: (2009)

The pharmacokinetics of D-penicillamine in normal and adjuvant arthritic rats
by: Aird, Sheelagh Ann
Published: (1987)

The eukaryotic flagellum in health and disease
by: Farr, Helen Katherine
Published: (2007)

Rapid analysis of pharmacology for infectious diseases
by: Carruthers, Ian Michael
Published: (2013)

The value of clonidine as an adjuvant to anaesthesia
by: Carabine, Una A.
Published: (1991)